Insider Trading & Ownership - Gerberding Julie L.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Gerberding Julie L.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2021-11-01
Sale		2021-11-03
4:11 pm		Merck & Co. Inc.MRKGerberding Julie L.
EVP, Chief Patient Officer		96,270$87.91$8,462,68271,691
(Direct)		View
2020-07-17
Sale		2020-07-20
4:53 pm		Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy		36,285$80$2,902,97626,577
(Direct)		View
2020-01-13
Sale		2020-01-15
5:15 pm		Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy		102,073$89.34$9,118,86537,038
(Direct)		View
2019-08-22
Sale		2019-08-23
4:11 pm		CERNER CorpCERNGerberding Julie L.
Director		7,928$71.82$569,3898,128
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-06-07
Option Award		2023-06-09
6:41 pm		N/A
2033-06-06		HilleVax Inc.HLVXGerberding Julie L.
Director		22,500$022,500
(Direct)		View
2022-08-19
Option Award		2022-08-23
4:36 pm		N/A
2032-08-18		HilleVax Inc.HLVXGerberding Julie L.
Director		25,000$025,000
(Direct)		View
2022-06-07
Equity Swap		2022-06-09
5:24 pm		N/A
N/A		CERNER CorpCERNGerberding Julie L.
Director		15,032$950
(Direct)		View

Ownership		2022-04-28
9:45 pm		N/A
N/A		HilleVax Inc.HLVXGerberding Julie L.
Director		0$042,025
(Direct)		View
2022-02-24
Option Award		2022-02-28
4:17 pm		N/A
N/A		Merck & Co. Inc.MRKGerberding Julie L.
EVP, Chief Patient Officer		9,550$73.5148,712
(Direct)		View
2021-11-01
Exercise		2021-11-03
4:11 pm		2018-05-05
2027-05-04		Merck & Co. Inc.MRKGerberding Julie L.
EVP, Chief Patient Officer		96,270$071,691
(Direct)		View

Ownership		2021-08-11
8:16 pm		N/A
N/A		AfterNext HealthTech Acquisition Corp.AFTRGerberding Julie L.
Director		0$040,000
(Direct)		View
2021-05-19
Option Award		2021-05-20
5:29 pm		N/A
N/A		CERNER CorpCERNGerberding Julie L.
Director		3,188$015,032
(Direct)		View
2021-05-04
Option Award		2021-05-06
4:43 pm		2022-05-04
2031-05-03		Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy		39,796$078,958
(Direct)		View
2021-02-26
Option Award		2021-03-02
11:46 am		N/A
N/A		Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy		12,585$72.6239,162
(Direct)		View
2020-07-17
Exercise		2020-07-20
4:53 pm		2017-05-10
2026-05-09		Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy		18,111$026,577
(Direct)		View
2020-05-22
Option Award		2020-05-27
4:12 pm		N/A
N/A		CERNER CorpCERNGerberding Julie L.
Director		3,716$011,844
(Direct)		View
2020-05-01
Option Award		2020-05-05
4:45 pm		2021-05-01
2030-04-30		Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy		33,226$077,977
(Direct)		View
2020-02-28
Option Award		2020-03-03
5:30 pm		N/A
N/A		Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy		7,371$76.5644,409
(Direct)		View
2020-01-13
Exercise		2020-01-15
5:15 pm		2016-05-01
2025-04-30		Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy		82,548$037,038
(Direct)		View
2019-05-30
Option Award		2019-06-03
4:10 pm		N/A
N/A		CERNER CORPCERNGerberding Julie L.
Director		3,556$016,056
(Direct)		View
2019-05-03
Option Award		2019-05-07
7:39 pm		2020-05-03
2029-05-02		Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy		28,227$083,837
(Direct)		View